Page last updated: 2024-11-02

pentamidine and B-Cell Chronic Lymphocytic Leukemia

pentamidine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
"We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy."1.35Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. ( Kovacs, JA; Masur, H, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovacs, JA1
Masur, H1
Gee, SN1
Rothschild, B1
Click, J1
Sheth, V1
Saavedra, A1
Hsu, MY1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Studies of Human Pneumocystis Infection[NCT00342589]1,500 participants (Anticipated)Observational1999-09-28Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for pentamidine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
    JAMA, 2009, Jun-24, Volume: 301, Issue:24

    Topics: Anti-Infective Agents; Antifungal Agents; Glucocorticoids; Humans; Immunocompromised Host; Leukemia,

2009
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucy

2011